WASHINGTON — The biotech industry’s largest trade group has parted ways with its top lobbyist, the group confirmed to STAT, adding to a recent bout of organizational tumult.
The departure of Nick Shipley may be part of a greater shakeup spearheaded by the Biotechnology Innovation Organization’s new CEO, John Crowley, who took over in December. An email sent to the group’s executive committee and obtained by STAT said that Crowley is “considering structural changes in the near future which could impact whether or not the role is permanently filled.”
Shipley’s last day as chief advocacy officer at BIO was Friday, and his profile has been removed from the group’s website. The departure was sudden, and he immediately packed up his office and left the building, according to three sources familiar with the departure.
Click this link for the original source of this article.
Author: Rachel Cohrs Zhang and John Wilkerson
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.